Wolf-Stefan Richter

medical imaging in drug development

image chain management - intelligent integration of imaging into clinical development plans, integrity of image end-point selection, imaging center qualification & training, image acquisition, storage & handling, blinded reads, evaluations and reporting

selection of imaging endpoints based on the investigational agent's mechanism of action, the pathophysiology of the disease in question, and clinical practice to generate "clean image data-sets" that directly address drug development and regulatory issues

Wolf S. Richter founded Pharmtrace in September 2006 to provide expertise and advice to drug developers in the integration and application of medical imaging to the drug development process.

His background encompasses almost 20 years’ experience in clinical practice, academic and industrial research. Prior to establishing pharmtrace, he was Head of Clinical Development Diagnostic Imaging / Radiopharmaceuticals and acting Head Digital Image Management in Schering AG, Berlin.

Wolf S. Richter is associate member of the faculty of Charité Medical School. He is specialized and board-certified as a nuclear medicine physician. During his clinical time, he was part the radiological and nuclear medicine services of Charité Medical School. He had the role of a senior physician for cardiovascular imaging. In addition, he established a small animal research lab and successfully studied isolated rat hearts using radiopharmaceutical methods. He published in excess of 40 original articles and more than 100 abstracts in addition to making regular conference contributions as an invited speaker.

MD, Specialisation in Nuclear Medicine; Foreign Medical Graduates Examination in the Medical Sciences (FMGEMS)

Education:

Studied Medicine in Berlin (Germany) and Rouen (France)
Specialisation in Nuclear Medicine
adjunct Professor (Priv.-Doz.) at Charité Medical School, Berlin

Experience:

Clinical (12 years) and pharmaceutical (5 years, Schering AG) background.
Main experience includes the use of Diagnostic Imaging (Radiology, Nuclear Medicine) in clinical studies.

Areas of Expertise:

Clinical Development, R&D Strategies